Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|February 15, 2026
Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational studyRaed Alroughani, Samar Farouk Ahmed
Multiple Sclerosis and Related Disorders|February 2, 2025
Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Clinical Neurology and Neurosurgery|March 21, 2024
Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Frontiers in Neurology|August 17, 2019
Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents: A Community Based StudyJasem Yousef Al-Hashel, Samar Farouk Ahmed, Raed Alroughani
Neuroepidemiology|July 21, 2017
Prevalence of Primary Headache Disorders in KuwaitJasem Yousef Al-Hashel, Samar Farouk Ahmed, Raed Alroughani
The Journal of Headache and Pain|October 15, 2017
Burden of migraine in a Kuwaiti population: a door-to-door surveyJasem Yousef Al-Hashel, Samar Farouk Ahmed, Raed Alroughani
Neurology and Therapy|August 7, 2017
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World EvidenceRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.
Multiple Sclerosis and Related Disorders|August 26, 2023
Real world study of ocrelizumab in multiple sclerosis: Kuwait experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Multiple Sclerosis and Related Disorders|April 13, 2023
A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Ocrelizumab for pediatric relapsing multiple sclerosisRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Pageof 5